Aveanna Healthcare Holdings Inc.

Item 8.01 Other Events. On May 26, 2026, Aveanna Healthcare LLC, a Delaware limited liability company (the "Borrower"), a wholly owned subsidiary of Aveanna Healthcare Holdings, Inc. (the "Company"), entered into the thirteenth amendment (the "Amendment") to its First Lien Credit Agreement, dated as of March 16, 2017 (as further amended, supplemented, or otherwise modified from time to time as of the date hereof, the "Existing Credit Agreement"), among the Borrower, Aveanna Healthcare Intermediate Holdings LLC, as Holdings, the subsidiaries of the Borrower party thereto, the lenders party thereto, Barclays Bank PLC as administrative agent and collateral agent, and other agents party thereto (the Existing Credit Agreement, as amended by the Amendment, the "Credit Agreement"). The Amendment constitutes a repricing of the facilities under the Existing Credit Agreement resulting in a 0.50% reduction to applicable interest rate margins. Pursuant to the Amendment, the outstanding senior secured term loans under the Existing Credit Agreement were refinanced with new senior secured term loans in an aggregate principal amount of $1,318,375,000 (the “2026 Term Loans”) and the existing $250,000,000 senior secured revolving credit facility was refinanced with a new $250,000,000 senior secured revolving credit facility (the “2026 Refinancing Revolving Credit Facility” and, together with the 2026 Term Loans, the “2026 Facilities”). The 2026 Term Loans bear interest at a rate equal to, at the election of the Borrower, Term SOFR plus an applicable margin equal to 3.25% per annum or a base rate plus an applicable margin equal to 2.25% per annum. Loans under the 2026 Refinancing Revolving Credit Facility bear interest at a rate equal to, at the election of the Borrower, Term SOFR plus an applicable margin equal to 3.25% per annum or a base rate plus an applicable margin equal to 2.25% per annum, subject to adjustments based on Consolidated First Lien Net Leverage Ratio (as defined in the Credit Agreement) as of the last day of the preceding fiscal quarter. The Amendment further provides for a reduction of 0.25% to the applicable margins described above upon the Borrower obtaining a rating of at least B2 or B from certain credit rating agencies. Other terms and conditions in the Existing Credit Agreement were not materially amended as part of the Amendment. The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the Amendment, including exhibits thereto, which the Company intends to attach as an exhibit to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 27, 2026. On May 28, 2026, the Company issued a press release announcing the Amendment. The full text of the press release is included as Exhibit 99.1 to this Current Report on Form 8-K.